Opinion

Tinubu urges local production of medicines to cut import dependence

Published on by Sentinel Digest Editorial

Tinubu urges local production of medicines to cut import dependence
Tinubu urges local production of medicines to cut import dependence

President Tinubu says Nigeria must manufacture more of its own medicines and equipment, citing ₦24bn in waivers approved for 75 local producers since January 2025.

President Bola Tinubu has said Nigeria must produce far more of the medicines, diagnostics and medical equipment its people need, arguing that the country's heavy reliance on imports is hurting families and weakening the economy.

In an essay setting out his administration's health agenda, Mr Tinubu said the Presidential Initiative for Unlocking the Healthcare Value Chain (PVAC), established in October 2023, had begun attracting Nigerian and international investment into domestic manufacturing. The initiative forms part of the Nigeria Health Sector Renewal Investment Initiative (NHSRII), launched in December 2023 to give effect to the health commitments of the Renewed Hope Agenda.

The president said dependence on imported health products leaves households exposed to exchange-rate swings and supply disruptions abroad, while money spent on medical travel sustains expertise Nigeria needs at home.

“Nigeria’s healthcare needs should support a growing source of national prosperity,” he wrote, adding that Nigerians should expect the investments to deliver “dependable care, more affordable treatment and opportunities to earn a decent living.”

His administration signed an Executive Order in June 2024 granting tax and tariff relief on specified machinery, equipment and inputs used in local healthcare manufacturing. Between January 2025 and June 2026, more than ₦24 billion in waivers was approved for 75 manufacturers.

Ten factories producing priority health products are now being established, six of them in 2026, covering medicines, diagnostic tests, medical oxygen and mosquito nets.

The mosquito-net sector offers a clear example. Vestergaard began operations at Health Textiles Nigeria in September 2026 following a 2024 agreement with PVAC, while Harvestfield, an indigenous firm, is producing dual-ingredient nets. At full scale, the companies expect to manufacture more than 10 million nets annually and employ over 600 people.

The same ambition extends to diagnostics. Codix Bio's agreement with the Medicines Patent Pool, supported by the World Health Organization, provides for technology transfer from SD Biosensor to manufacture rapid diagnostic tests in Nigeria. NASENI-Troment is also using world-class technology to produce diagnostic kits locally, Mr Tinubu said.

He said investments in advanced diagnostics, cancer care and other specialist services should retain more health spending within Nigeria while sparing families the cost of treatment abroad.

Medipool, Nigeria's first nationally approved group purchasing organisation, was established to pool demand for quality medicines, negotiate better prices and offer local manufacturers a dependable market.

The president said announced investments must now move into production and reach the facilities where Nigerians receive care, adding that he expects the Coordinating Minister of Health and Social Welfare, Professor Muhammad Ali Pate, to sustain the work with relevant institutions and private partners.

Related Stories in Opinion